GETI B Stock Overview
Provides products and solutions for operating rooms, intensive-care units, and sterilization departments. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Getinge AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 166.70 |
| 52 Week High | SEK 240.20 |
| 52 Week Low | SEK 165.40 |
| Beta | 0.49 |
| 11 Month Change | -14.07% |
| 3 Month Change | -21.22% |
| 1 Year Change | -24.12% |
| 33 Year Change | -55.75% |
| 5 Year Change | -3.64% |
| Change since IPO | 376.29% |
Recent News & Updates
Recent updates
Getinge (STO:GETI B) Is Experiencing Growth In Returns On Capital
Oct 17
Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Sep 19Pinning Down Getinge AB (publ)'s (STO:GETI B) P/E Is Difficult Right Now
Aug 23An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued
Aug 08Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 21We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)
Jun 27Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly
May 11Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates
Apr 25Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?
Apr 15The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts
Mar 30Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's
Mar 29The Return Trends At Getinge (STO:GETI B) Look Promising
Mar 21Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results
Feb 04There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price
Jan 20Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Jan 05Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price
Dec 20Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)
Dec 05Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet
Oct 06Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?
Sep 21Getinge's (STO:GETI B) Returns On Capital Are Heading Higher
Sep 03Is Getinge (STO:GETI B) A Risky Investment?
Jun 28Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?
Jun 15Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist
Jun 01At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?
May 05Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25
Apr 05Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement
Feb 28Is Getinge AB (publ) (STO:GETI B) Trading At A 42% Discount?
Feb 16Getinge (STO:GETI B) Is Paying Out A Larger Dividend Than Last Year
Feb 04Is Getinge (STO:GETI B) Using Too Much Debt?
Feb 03When Should You Buy Getinge AB (publ) (STO:GETI B)?
Jan 07Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 49%?
Nov 06Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet
Oct 07We Think Getinge (STO:GETI B) Can Stay On Top Of Its Debt
Jun 25Shareholder Returns
| GETI B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -10.6% | -4.1% | -2.1% |
| 1Y | -24.1% | -9.7% | 10.8% |
Return vs Industry: GETI B underperformed the Swedish Medical Equipment industry which returned -4.1% over the past year.
Return vs Market: GETI B underperformed the Swedish Market which returned 12.5% over the past year.
Price Volatility
| GETI B volatility | |
|---|---|
| GETI B Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: GETI B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: GETI B's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 11,848 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Getinge AB (publ) Fundamentals Summary
| GETI B fundamental statistics | |
|---|---|
| Market cap | SEK 45.40b |
| Earnings (TTM) | SEK 1.69b |
| Revenue (TTM) | SEK 33.59b |
26.9x
P/E Ratio1.4x
P/S RatioIs GETI B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GETI B income statement (TTM) | |
|---|---|
| Revenue | SEK 33.59b |
| Cost of Revenue | SEK 18.21b |
| Gross Profit | SEK 15.39b |
| Other Expenses | SEK 13.69b |
| Earnings | SEK 1.69b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 28, 2025
| Earnings per share (EPS) | 6.21 |
| Gross Margin | 45.80% |
| Net Profit Margin | 5.03% |
| Debt/Equity Ratio | 30.0% |
How did GETI B perform over the long term?
See historical performance and comparison